AGL agilon health Inc

$1.32

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/22/2025

About agilon health Inc

agilon health, inc. The company is headquartered in Long Beach, California.

Website: https://www.agilonhealth.com

Sector
LIFE SCIENCES
Industry
SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1831097
Address
1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH, CA, US
Valuation
Market Cap
$1.65B
P/E Ratio
nan
PEG Ratio
nan
Price to Book
3.50
Performance
EPS
$-0.61
Dividend Yield
—
Profit Margin
-4.29%
ROE
-44.20%
Technicals
50D MA
$4.05
200D MA
$3.75
52W High
$7.73
52W Low
$1.50
Fundamentals
Shares Outstanding
412M
Target Price
$4.11
Beta
0.39

AGL EPS Estimates vs Actual

● Estimated
● Actual

AGL News & Sentiment

Aug 21, 2025 • Benzinga NEUTRAL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL - Agilon Health ( NYSE:AGL )
NEW YORK, Aug. 21, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ( "agilon" or the "Company" ) AGL. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Aug 20, 2025 • Benzinga SOMEWHAT-BULLISH
This Applied Materials Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Applied Mat ( NASDAQ:AMAT ) , Agilon Health ( NYSE:AGL )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Bernstein analyst Lance Wilkes downgraded agilon health, inc.
Aug 20, 2025 • Zacks Commentary NEUTRAL
New Strong Sell Stocks for August 20th
AGL, CCRN and GOGL have been added to the Zacks Rank #5 (Strong Sell) List on August 20, 2025.
Aug 13, 2025 • Benzinga SOMEWHAT-BULLISH
Intapp Posts Better-Than-Expected Earnings, Joins Sapiens International, Arcturus Therapeutics, Gildan Activewear And Other Big Stocks Moving Higher On Wednesday - Agilon Health ( NYSE:AGL ) , Arcturus Therapeutics ( NASDAQ:ARCT )
U.S. stocks were higher, with the Dow Jones index gaining around 250 points on Wednesday. Shares of Intapp, Inc. INTA rose sharply during Wednesday's session after the company reported better-than-expected fourth-quarter financial results.
Aug 11, 2025 • Benzinga NEUTRAL
AGILON ALERT: Bragar Eagel & Squire, P.C. is Investigating Agilon Health, Inc. on Behalf of Agilon Stockholders and Encourages Investors to Contact the Firm - Agilon Health ( NYSE:AGL )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Agilon ( AGL ) To Contact Him Directly To Discuss Their Options
Aug 09, 2025 • Benzinga NEUTRAL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL - Agilon Health ( NYSE:AGL )
NEW YORK, Aug. 09, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ( "agilon" or the "Company" ) AGL. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Sentiment Snapshot

Average Sentiment Score:

0.031
50 articles with scored sentiment

Overall Sentiment:

Neutral

AGL Reported Earnings

May 05, 2025
Mar 31, 2025 (Post market)
0.0 Surprise
  • Reported EPS: $0.00
  • Estimate: $0.00
  • Whisper: —
  • Surprise %: 0.0%
Feb 25, 2025
Dec 31, 2024 (Pre market)
-0.12 Surprise
  • Reported EPS: $-0.25
  • Estimate: $-0.13
  • Whisper: —
  • Surprise %: -95.3%
Nov 07, 2024
Sep 30, 2024 (Post market)
-0.18 Surprise
  • Reported EPS: $-0.29
  • Estimate: $-0.11
  • Whisper: —
  • Surprise %: -163.6%
Aug 06, 2024
Jun 30, 2024 (Post market)
0.01 Surprise
  • Reported EPS: $-0.07
  • Estimate: $-0.08
  • Whisper: —
  • Surprise %: 12.5%
May 07, 2024
Mar 31, 2024 (Post market)
0.0 Surprise
  • Reported EPS: $-0.01
  • Estimate: $-0.01
  • Whisper: —
  • Surprise %: 0.0%
Feb 27, 2024
Dec 31, 2023 (Post market)
-0.11 Surprise
  • Reported EPS: $-0.41
  • Estimate: $-0.30
  • Whisper: —
  • Surprise %: -36.7%
Nov 02, 2023
Sep 30, 2023 (Post market)
-0.02 Surprise
  • Reported EPS: $-0.08
  • Estimate: $-0.06
  • Whisper: —
  • Surprise %: -33.3%
Aug 03, 2023
Jun 30, 2023 (Post market)
-0.01 Surprise
  • Reported EPS: $-0.04
  • Estimate: $-0.03
  • Whisper: —
  • Surprise %: -33.3%
May 09, 2023
Mar 31, 2023 (Post market)
0.02 Surprise
  • Reported EPS: $0.04
  • Estimate: $0.02
  • Whisper: —
  • Surprise %: 100.0%

Financials